Results of the large multicenter prospective validation study, organized by the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO. group, confirming positive prediction of surgical outcome in patients with recurrent ovarian cancer based on 3 parameters.